Literature DB >> 2821186

Properties of a hepatitis A virus candidate vaccine strain.

U Heinricy1, Y D Stierhof, M Pfisterer, B Flehmig.   

Abstract

This paper describes the biophysical and biochemical properties as well as electron microscopical studies of a candidate hepatitis A vaccine strain propagated in human fibroblast cells. Our results indicated that, in CsCl, the density of hepatitis A virus (HAV) from cell culture supernatant and of HAV extracted from infected cells was influenced by the quantity of lipid material associated with HAV. Antigenicity of untreated HAV, therefore, was detected primarily in low density CsCl fractions (1.11 g/ml, 1.21 g/ml). After lipid reduction with NP40 detergent or chloroform/Genetron, antigenicity and infectivity were primarily detected in high density CsCl fractions (1.31 g/ml). Electron microscopy demonstrated a strong association between membranous material and virus particles of low density in CsCl as well as virus-like particles in ultrathin sections of HAV-infected human fibroblast cells. The uncovered virus particles banded in the 1.31 g/ml dense CsCl fraction lacked lipid material. The s value was 79 for 1.19 g/ml to 1.22 g/ml dense HAV and 147 for 1.29 g/ml to 1.33 g/ml HAV. Autoradiography of the radioiodinated dense HAV revealed some proteins with high Mr (120K to 67K) and others with low Mr (37K to 15K).

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2821186     DOI: 10.1099/0022-1317-68-9-2487

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  5 in total

1.  Immune response to hepatitis A virus capsid proteins after infection.

Authors:  C H Wang; S Y Tschen; U Heinricy; M Weber; B Flehmig
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

Review 2.  Clinical development of a new inactivated hepatitis A vaccine.

Authors:  E Vidor; B Fritzell; S Plotkin
Journal:  Infection       Date:  1996 Nov-Dec       Impact factor: 3.553

3.  Nucleotide sequence of wild-type hepatitis A virus GBM in comparison with two cell culture-adapted variants.

Authors:  J Graff; A Normann; S M Feinstone; B Flehmig
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

4.  Assessment of packed bed bioreactor systems in the production of viral vaccines.

Authors:  Ramya Rajendran; Rajendra Lingala; Siva Kumar Vuppu; Bala Obulapathi Bandi; Elaiyaraja Manickam; Sankar Rao Macherla; Stéphanie Dubois; Nicolas Havelange; Kapil Maithal
Journal:  AMB Express       Date:  2014-04-25       Impact factor: 3.298

5.  A rapid Orthopoxvirus purification protocol suitable for high-containment laboratories.

Authors:  Laura Hughes; Kimberly Wilkins; Cynthia S Goldsmith; Scott Smith; Paul Hudson; Nishi Patel; Kevin Karem; Inger Damon; Yu Li; Victoria A Olson; P S Satheshkumar
Journal:  J Virol Methods       Date:  2017-01-26       Impact factor: 2.623

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.